In particular, ASA was also shown to inhibit the NF-κB and Wnt signaling paths, both involved in the progression of aggressive thyroid cancers [2,13,22,30,31,32,33,34,35]. The gene discussed is NFKB1; the disease is thyroid gland carcinoma.